Prosecutors showed that Bacanovic had ordered his assistant to tell Stewart that the CEO of ImClone, Samuel D. Waksal, was selling all his shares in advance of an adverse Food and Drug Administration ruling.
Procurorii au arătat că Bacanovic a ordonat asistentul său de a spune Stewart, care CEO-ul de ImClone, Samuel D. Waksal, a fost vandut toate actiunile în avans de un adverse Food and Drug Administration de guvernământ.